Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 4,000 shares at $12.84 ($48K) on 2025-02-05, disclosed to the SEC on 2025-02-06.
Scheduled sale ($48k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.62 | 2,000 | $23K | 48.4% |
| 2 | $12.39 | 1,980 | $25K | 51.1% |
| 3 | $12.84 | 20 | $257 | 0.5% |
| Total | $12.01 avg | 4,000 | $48K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |